Zydus Lifesciences LtdPharmaceuticalsINE010B01027Consolidated₹1160.00+24.90 (+2.19%)Jun-26
Valuation
Market Cap₹1.16L Cr
TTM PE25.85x
Forward PE26.89x
PEG-2.48
Book Value₹271.79
P/B4.27x
TTM EPS₹44.87
Fwd EPS₹43.15
TTM Revenue₹28.59K Cr
TTM PAT₹4.59K Cr
TTM EBITDA₹8.32K Cr
TTM EBIT₹6.59K Cr
Last Qtr PAT₹990.20 Cr
Last Qtr EBITDA₹1.93K Cr
Last Qtr EBIT₹1.37K Cr
Profitability
ROE16.94%
ROCE16.45%
TTM NPM16.06%
TTM EBITDA %29.09%
Curr OPM12.19%
Last OPM17.37%
Curr NPM—
Last NPM—
Curr EPS₹9.35
Last EPS₹12.65
Balance sheet
Equity₹100.60 Cr
Reserve₹27.01K Cr
Total Debt₹12,496.00 Cr
D/E0.46x
Interest %15.75%
Curr Interest₹156.00 Cr
Price / range
Close₹1160.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.19%
1W+3.65%
1M+3.98%
3M+7.97%
6M+29.07%
1Y+10.70%
2Y+7.47%
3Y+80.28%
5Y+108.18%
Diwali+26.85%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits